The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer
- PMID: 29532360
- DOI: 10.1007/s11605-018-3726-9
The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer
Abstract
Background: This study aimed to evaluate the additional value of laparoscopic ultrasound (LUS) to staging laparoscopy (SL) for detecting occult liver metastases in patients with potentially resectable pancreatic head cancer.
Methods: A retrospective cohort study was performed including all patients who underwent SL and LUS between 2005 and 2016. LUS was performed during SL to detect liver metastases not found by preoperative imaging or visual inspection of the liver.
Results: Out of 197 patients, visual inspection during SL detected distant metastases in 29 (14.7%) patients. LUS was performed in 127 patients, revealing 3 additional liver metastases. The proportion of patients with unresectable disease after SL and negative LUS was 32.3%, which was similar to 36.6% of patients with unresectable disease after SL without LUS (difference 4.3%; 95% CI - 13-23%; P = 0.61). Sensitivity, specificity, and positive and negative predictive values of LUS to detect liver metastases were 30, 100, 100, and 94%, respectively. The proportion of patients with distant metastases diagnosed at SL significantly increased over time (P = 0.031).
Conclusion: The routine use of LUS during SL for patients with potentially resectable pancreatic head cancer cannot be recommended. Imaging should be repeated when significant delay occurs between index CT and the scheduled surgery.
Keywords: Laparoscopic ultrasound; Pancreas; Pancreatic cancer; Pancreatic surgery; Staging laparoscopy.
Similar articles
-
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.Dan Med J. 2012 Dec;59(12):B4568. Dan Med J. 2012. PMID: 23290296 Review.
-
Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.PLoS One. 2018 Nov 1;13(11):e0205960. doi: 10.1371/journal.pone.0205960. eCollection 2018. PLoS One. 2018. PMID: 30383818 Free PMC article.
-
Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy.J Am Coll Surg. 1997 Jul;185(1):33-9. J Am Coll Surg. 1997. PMID: 9208958
-
Laparoscopy and laparoscopic ultrasonography in judging the resectability of pancreatic head cancer.Hepatobiliary Pancreat Dis Int. 2003 Nov;2(4):609-11. Hepatobiliary Pancreat Dis Int. 2003. PMID: 14627530
-
The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of patients with resectable colorectal liver metastases: a meta-analysis.Am J Surg. 2012 Jul;204(1):84-92. doi: 10.1016/j.amjsurg.2011.07.018. Epub 2012 Jan 14. Am J Surg. 2012. PMID: 22244586 Review.
Cited by
-
Has the non-resection rate decreased during the last two decades among patients undergoing surgical exploration for pancreatic adenocarcinoma?BMC Surg. 2020 Aug 5;20(1):176. doi: 10.1186/s12893-020-00835-3. BMC Surg. 2020. PMID: 32758203 Free PMC article.
-
Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis.Pleura Peritoneum. 2024 Sep 6;9(3):107-112. doi: 10.1515/pp-2024-0007. eCollection 2024 Sep. Pleura Peritoneum. 2024. PMID: 39544431 Free PMC article.
-
Laparoscopic ultrasonography along with staging laparoscopy as a tool for staging in patients with hepatopancreaticobiliary malignancy - A prospective cohort study from a tertiary care centre.J Minim Access Surg. 2024 Jan 1;20(1):96-101. doi: 10.4103/jmas.jmas_354_22. Epub 2023 Oct 18. J Minim Access Surg. 2024. PMID: 38240385 Free PMC article.
-
Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection?Langenbecks Arch Surg. 2020 Feb;405(1):35-41. doi: 10.1007/s00423-019-01846-2. Epub 2019 Nov 28. Langenbecks Arch Surg. 2020. PMID: 31781919
-
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.Front Oncol. 2021 Jul 15;11:688377. doi: 10.3389/fonc.2021.688377. eCollection 2021. Front Oncol. 2021. PMID: 34336673 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical